Eleni Nakou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Eleni Nakou has a total of 122 co-authors. Here are the top co-authors by number of shared publications:
Panos E. Vardas
Department of Cardiology, Heraklion University Hospital, Greece
4 shared publicationsFragiskos I. Parthenakis
Department of Cardiology, Heraklion University Hospital, Greece
3 shared publications- Priyanka Boettger
Department of Internal Medicine I, Cardiology, Angiology and Intensive Care Medicine, Justus-Liebig-University, Giessen, Germany
3 shared publications Alexandros Patrianakos
Cardiology Department, University Hospital of Heraklion, University of Crete Medical School, Heraklion, Crete, Greece
2 shared publications- Chiara Bucciarelli-Ducci
Royal Brompton and Harefield Hospitals, Guys and St Thomas NHS Foundation Trust , London SW3 6NP
2 shared publications Maria E. Marketou
Department of Cardiology, Heraklion University Hospital, Greece
2 shared publications
Latest Publications
- Open Access
- 2 October 2026
- Published by Elsevier in Hellenic Journal of Cardiology
The EU Safe Hearts Plan and Greece: implementation considerations and opportunities
- 2 October 2026
- Published by Elsevier in Hellenic Journal of Cardiology
Open AccessThe EU Safe Hearts Plan and Greece: implementation considerations and opportunities
- Open Access
- 1 October 2026
- Published by MDPI AG in Health Economics and Policy
- Vol. 1 (2) , 9
Beyond Readmission Penalties: A Health-Policy Framework for Governing Post-Acute Cardiovascular Care
Acute cardiovascular care is among the most resource-intensive domains of contemporary healthcare. Major investments are concentrated in the index hospital episode, including emergency diagnostics, reperfusion or revascularization, intensive monitoring, specialist pharmacotherapy and multidisciplinary stabilization. Yet a substantial share of this value may be lost after discharge, when patients enter fragmented outpatient pathways characterized by delayed follow-up, medication discrepancies, unclear accountability and inconsistent implementation of secondary prevention. This paper uses the discharge cliff as an organizing metaphor for that phenomenon. We argue that the discharge cliff is not only a clinical problem but also a health-economic and sustainability problem. When responsibility becomes discontinuous after discharge, high-cost acute gains are exposed to avoidable erosion. The result is recurrent emergency use, repeat diagnostic cascades, duplicated medicines work, potentially preventable rehospitalization and additional material consumption. These consequences are relevant after acute myocardial infarction, decompensated heart failure, cardiogenic shock survivorship and stroke with cardiovascular complications, where the post-discharge period is both vulnerable and management intensive. Drawing on cardiovascular guidelines, outcomes research, policy documents and sustainability literature, we organize the synthesis around three recurring governance mechanisms: discontinuity of accountability, misaligned reimbursement incentives and weak post-acute feedback loops. We then propose a framework of post-acute cardiovascular stewardship. Core levers include structured discharge-to-follow-up pathways, pharmacist-supported medicines optimization, early specialist review, digital monitoring for high-risk patients, accountable transition metrics, and bundled or episode-based payment models. Clinical continuity and economic stewardship form the operational core of the framework; environmental resource use is included as an emerging, cross-cutting dimension whose pathway-level quantification remains less mature. The vulnerability of the post-discharge period is well established. The contribution here is not a new clinical phenomenon but a reframing of that established failure as a problem of value preservation and governance, and its operationalization into accountable ownership, episode-level measurement and reimbursement design. The sustainable future of high-intensity cardiovascular care depends not only on saving lives in hospital, but also on preserving the value generated there once the patient returns to community care.
- 1 October 2026
- Published by MDPI AG in Health Economics and Policy
- Vol. 1 (2) , 9
Open AccessBeyond Readmission Penalties: A Health-Policy Framework for Governing Post-Acute Cardiovascular Care
Acute cardiovascular care is among the most resource-intensive domains of contemporary healthcare. Major investments are concentrated in the index hospital episode, including emergency diagnostics, reperfusion or revascularization, intensive monitoring, specialist pharmacotherapy and multidisciplinary stabilization. Yet a substantial share of this value may be lost after discharge, when patients enter fragmented outpatient pathways characterized by delayed follow-up, medication discrepancies, unclear accountability and inconsistent implementation of secondary prevention. This paper uses the discharge cliff as an organizing metaphor for that phenomenon. We argue that the discharge cliff is not only a clinical problem but also a health-economic and sustainability problem. When responsibility becomes discontinuous after discharge, high-cost acute gains are exposed to avoidable erosion. The result is recurrent emergency use, repeat diagnostic cascades, duplicated medicines work, potentially preventable rehospitalization and additional material consumption. These consequences are relevant after acute myocardial infarction, decompensated heart failure, cardiogenic shock survivorship and stroke with cardiovascular complications, where the post-discharge period is both vulnerable and management intensive. Drawing on cardiovascular guidelines, outcomes research, policy documents and sustainability literature, we organize the synthesis around three recurring governance mechanisms: discontinuity of accountability, misaligned reimbursement incentives and weak post-acute feedback loops. We then propose a framework of post-acute cardiovascular stewardship. Core levers include structured discharge-to-follow-up pathways, pharmacist-supported medicines optimization, early specialist review, digital monitoring for high-risk patients, accountable transition metrics, and bundled or episode-based payment models. Clinical continuity and economic stewardship form the operational core of the framework; environmental resource use is included as an emerging, cross-cutting dimension whose pathway-level quantification remains less mature. The vulnerability of the post-discharge period is well established. The contribution here is not a new clinical phenomenon but a reframing of that established failure as a problem of value preservation and governance, and its operationalization into accountable ownership, episode-level measurement and reimbursement design. The sustainable future of high-intensity cardiovascular care depends not only on saving lives in hospital, but also on preserving the value generated there once the patient returns to community care.
- Open Access
- 11 September 2026
- Published by Elsevier in Health Policy
- Vol. 174, 105770
Measuring and governing potentially low-value invasive coronary angiography in Europe: a systematic review, construct-specific meta-analysis, and policy framework
- 11 September 2026
- Published by Elsevier in Health Policy
- Vol. 174, 105770
Open AccessMeasuring and governing potentially low-value invasive coronary angiography in Europe: a systematic review, construct-specific meta-analysis, and policy framework
- 1 January 2026
- Published by Kare Publishing in The Anatolian Journal of Cardiology
Aviation Medicine and Cardiovascular Assessment of Aircrew: A European Society of Cardiology–Aligned Review of Integrating International Civil Aviation Organization, European Union Aviation Safety Agency, Federal Aviation Administration, and Turkish Directorate General of Civil Aviation Aeromedical Standards
Aeromedical certification is based on a safety-first principle: a pilot or other aircrew member must not have a medical disorder that creates an unacceptable risk of sudden or subtle incapacitation during flight. Cardiovascular disease remains one of the most important determinants of flight fitness, as it may impair consciousness, judgment, rhythm stability, exercise capacity, and hemodynamic reserve. Modern aeromedical decision-making therefore requires the integration of aviation law, operational risk, contemporary cardiology guidelines, advanced imaging, biomarkers, and long-term surveillance. The International Civil Aviation Organization (ICAO) Annex 1 provides the global licensing framework; the European Union Aviation Safety Agency (EASA) Part-MED, together with its Acceptable Means of Compliance and Guidance Material, defines detailed operational standards in Europe; and the Federal Aviation Administration (FAA) employs a protocol- and special issuance–based system for many cardiovascular and metabolic disorders. This review summarizes the aeromedical assessment of hypertension, diabetes mellitus, chronic and acute coronary syndromes, heart failure, cardiomy-opathies, arrhythmias and conduction disorders, pacemakers and implantable cardiac devices, valvular heart disease, aortic disease, congenital heart disease, venous throm-boembolism, cardiovascular pharmacotherapy, and major respiratory conditions rel-evant to flight certification. The manuscript is aligned with current European Society of Cardiology cardiovascular guidance and with the operational aeromedical principles applied by ICAO, EASA, FAA, and the Turkish Directorate General of Civil Aviation. In general, preserved ventricular function, absence of significant symptoms, low thrombo-embolic and arrhythmic risk, stable treatment, and adequate exercise capacity support certification or restricted certification. In contrast, uncontrolled hypertension, unstable diabetes, significant residual myocardial ischemia, reduced ejection fraction, malignant ventricular arrhythmias, implantable defibrillator therapy, severe valvular disease, significant aortic pathology, major congenital hemodynamic lesions, or poorly controlled sleep apnea usually preclude certification. Final decisions remain individualized and depend on license class, operational role, treatment burden, surveillance data, and the judgment of the aeromedical authority.
- 1 January 2026
- Published by Kare Publishing in The Anatolian Journal of Cardiology
Aviation Medicine and Cardiovascular Assessment of Aircrew: A European Society of Cardiology–Aligned Review of Integrating International Civil Aviation Organization, European Union Aviation Safety Agency, Federal Aviation Administration, and Turkish Directorate General of Civil Aviation Aeromedical Standards
Aeromedical certification is based on a safety-first principle: a pilot or other aircrew member must not have a medical disorder that creates an unacceptable risk of sudden or subtle incapacitation during flight. Cardiovascular disease remains one of the most important determinants of flight fitness, as it may impair consciousness, judgment, rhythm stability, exercise capacity, and hemodynamic reserve. Modern aeromedical decision-making therefore requires the integration of aviation law, operational risk, contemporary cardiology guidelines, advanced imaging, biomarkers, and long-term surveillance. The International Civil Aviation Organization (ICAO) Annex 1 provides the global licensing framework; the European Union Aviation Safety Agency (EASA) Part-MED, together with its Acceptable Means of Compliance and Guidance Material, defines detailed operational standards in Europe; and the Federal Aviation Administration (FAA) employs a protocol- and special issuance–based system for many cardiovascular and metabolic disorders. This review summarizes the aeromedical assessment of hypertension, diabetes mellitus, chronic and acute coronary syndromes, heart failure, cardiomy-opathies, arrhythmias and conduction disorders, pacemakers and implantable cardiac devices, valvular heart disease, aortic disease, congenital heart disease, venous throm-boembolism, cardiovascular pharmacotherapy, and major respiratory conditions rel-evant to flight certification. The manuscript is aligned with current European Society of Cardiology cardiovascular guidance and with the operational aeromedical principles applied by ICAO, EASA, FAA, and the Turkish Directorate General of Civil Aviation. In general, preserved ventricular function, absence of significant symptoms, low thrombo-embolic and arrhythmic risk, stable treatment, and adequate exercise capacity support certification or restricted certification. In contrast, uncontrolled hypertension, unstable diabetes, significant residual myocardial ischemia, reduced ejection fraction, malignant ventricular arrhythmias, implantable defibrillator therapy, severe valvular disease, significant aortic pathology, major congenital hemodynamic lesions, or poorly controlled sleep apnea usually preclude certification. Final decisions remain individualized and depend on license class, operational role, treatment burden, surveillance data, and the judgment of the aeromedical authority.
- Open Access
- 23 September 2022
- Published by Radcliffe Medical Media Ltd in Cardiac Failure Review
- Vol. 8, e29
Imaging in Women with Heart Failure: Sex-specific Characteristics and Current Challenges
Cardiovascular disease (CVD) represents a significant threat to women’s health. Heart failure (HF) is one CVD that still has an increasing incidence and about half of all cases involve women. HF is characterised by strong sex-specific features in aetiology, clinical manifestation and outcomes. Women are more likely to have hypertensive heart disease and HF with preserved ejection fraction, they experience worse quality of life but have a better overall survival rate. Women’s hearts also have unique morphological characteristics that should be considered during cardiovascular assessment. It is important to understand and highlight these sex-specific features to be able to provide a tailored diagnostic approach and therapeutic management. The aim of this article is to review these aspects together with the challenges and the unique characteristics of different imaging modalities used for the diagnosis and follow-up of women with HF.
- 23 September 2022
- Published by Radcliffe Medical Media Ltd in Cardiac Failure Review
- Vol. 8, e29
Open AccessImaging in Women with Heart Failure: Sex-specific Characteristics and Current Challenges
Cardiovascular disease (CVD) represents a significant threat to women’s health. Heart failure (HF) is one CVD that still has an increasing incidence and about half of all cases involve women. HF is characterised by strong sex-specific features in aetiology, clinical manifestation and outcomes. Women are more likely to have hypertensive heart disease and HF with preserved ejection fraction, they experience worse quality of life but have a better overall survival rate. Women’s hearts also have unique morphological characteristics that should be considered during cardiovascular assessment. It is important to understand and highlight these sex-specific features to be able to provide a tailored diagnostic approach and therapeutic management. The aim of this article is to review these aspects together with the challenges and the unique characteristics of different imaging modalities used for the diagnosis and follow-up of women with HF.
- 11 November 2021
- Published by Springer Nature in Current Cardiology Reports
- Vol. 23 (12) , 1-11
Cardiovascular Magnetic Resonance Parametric Mapping Techniques: Clinical Applications and Limitations
Purpose of Review Parametric mapping represents a significant innovation in cardiovascular magnetic resonance (CMR) tissue characterisation, allowing the quantification of myocardial changes based on changes on T1, T2 and T2* relaxation times and extracellular volume (ECV). Its clinical use is rapidly expanding, but it requires availability of dedicated equipment as well as expertise in image acquisition and analysis. This review focuses on the principles of CMR parametric mapping, its current clinical applications, important limitations, as well as future directions of this technique in cardiovascular medicine. Recent Findings There is increasing evidence that CMR parametric mapping techniques provide accurate diagnostic and prognostic tools that can be applied to and support the clinical management of patients with a range of cardiovascular disease. Summary The unique capability of CMR myocardial tissue characterisation in cardiovascular diseases has further expanded by the introduction of parametric mapping. Its use in clinical practice presents opportunities but has also limitations.
- 11 November 2021
- Published by Springer Nature in Current Cardiology Reports
- Vol. 23 (12) , 1-11
Cardiovascular Magnetic Resonance Parametric Mapping Techniques: Clinical Applications and Limitations
Purpose of Review Parametric mapping represents a significant innovation in cardiovascular magnetic resonance (CMR) tissue characterisation, allowing the quantification of myocardial changes based on changes on T1, T2 and T2* relaxation times and extracellular volume (ECV). Its clinical use is rapidly expanding, but it requires availability of dedicated equipment as well as expertise in image acquisition and analysis. This review focuses on the principles of CMR parametric mapping, its current clinical applications, important limitations, as well as future directions of this technique in cardiovascular medicine. Recent Findings There is increasing evidence that CMR parametric mapping techniques provide accurate diagnostic and prognostic tools that can be applied to and support the clinical management of patients with a range of cardiovascular disease. Summary The unique capability of CMR myocardial tissue characterisation in cardiovascular diseases has further expanded by the introduction of parametric mapping. Its use in clinical practice presents opportunities but has also limitations.
- 2 December 2020
- Published by SAGE Publications in Journal of Endovascular Therapy
- Vol. 28 (2) , 352-359
Early Left Ventricular Global Longitudinal Strain Deterioration After Aortic Aneurysm Repair: Impact of Aortic Stiffness
Purpose: To associate the impact of aortic reconstruction using currently available grafts and endografts on pulse wave velocity in patients with abdominal aortic aneurysm (AAA) and to evaluate its effect on early cardiac systolic function indices. Materials and Methods: Seventy-three consecutive patients with AAA (mean age 70±8 years; all men) who underwent open (n=12) or endovascular repair (EVAR; n=61) were prospectively enrolled in an observational cohort study. Left ventricular global longitudinal strain (GLS; an important diagnostic and prognostic index of early systolic dysfunction) and carotid-femoral pulse wave velocity (cf-PWV) were estimated 1 week preoperatively, as well as at 1 and 6 months postoperatively. Results: A significant time effect was found for cf-PWV, which showed an increase at 1 month that remained through 6 months (p=0.007). Additionally, a deterioration in GLS values was revealed, with a significant change at 1 month that persisted 6 months later (p<0.001). No significant group effect was observed between EVAR and open repair (p=0.98), and there was no significant interaction (p=0.96). Notably, the difference in GLS between baseline and 6 months significantly correlated with the corresponding changes in cf-PWV (r=0.494, p<0.001). Conclusion: AAA repair leads not only to an increase in aortic stiffness, as measured by the increase in pulse wave velocity, but also to reduced cardiac systolic function. Our findings highlight the need for a more intense cardiac surveillance program after aortic reconstruction. Further studies are needed to investigate how this may translate into long-term manifestations of cardiovascular complications and symptomatology.
- 2 December 2020
- Published by SAGE Publications in Journal of Endovascular Therapy
- Vol. 28 (2) , 352-359
Early Left Ventricular Global Longitudinal Strain Deterioration After Aortic Aneurysm Repair: Impact of Aortic Stiffness
Purpose: To associate the impact of aortic reconstruction using currently available grafts and endografts on pulse wave velocity in patients with abdominal aortic aneurysm (AAA) and to evaluate its effect on early cardiac systolic function indices. Materials and Methods: Seventy-three consecutive patients with AAA (mean age 70±8 years; all men) who underwent open (n=12) or endovascular repair (EVAR; n=61) were prospectively enrolled in an observational cohort study. Left ventricular global longitudinal strain (GLS; an important diagnostic and prognostic index of early systolic dysfunction) and carotid-femoral pulse wave velocity (cf-PWV) were estimated 1 week preoperatively, as well as at 1 and 6 months postoperatively. Results: A significant time effect was found for cf-PWV, which showed an increase at 1 month that remained through 6 months (p=0.007). Additionally, a deterioration in GLS values was revealed, with a significant change at 1 month that persisted 6 months later (p<0.001). No significant group effect was observed between EVAR and open repair (p=0.98), and there was no significant interaction (p=0.96). Notably, the difference in GLS between baseline and 6 months significantly correlated with the corresponding changes in cf-PWV (r=0.494, p<0.001). Conclusion: AAA repair leads not only to an increase in aortic stiffness, as measured by the increase in pulse wave velocity, but also to reduced cardiac systolic function. Our findings highlight the need for a more intense cardiac surveillance program after aortic reconstruction. Further studies are needed to investigate how this may translate into long-term manifestations of cardiovascular complications and symptomatology.
- Open Access
- 1 November 2020
- Published by Elsevier in Hellenic Journal of Cardiology
- Vol. 61 (6) , 362-377
Cardiovascular disease in women: Executive summary of the expert panel statement of women in cardiology of the hellenic cardiological society
- 1 November 2020
- Published by Elsevier in Hellenic Journal of Cardiology
- Vol. 61 (6) , 362-377
Open AccessCardiovascular disease in women: Executive summary of the expert panel statement of women in cardiology of the hellenic cardiological society
- 1 November 2020
- Published by Wiley in Echocardiography
- Vol. 37 (11) , 1855-1859
Isolated papillary muscle rupture with nonobstructive coronary artery disease, minimal myocardial infarction, and normal wall motion
Papillary muscle (PM) rupture can usually complicate inferior or posterior myocardial infarctions, but selective PM infarction is extremely rare, and the exact underlying pathophysiological mechanism is not entirely clear. We present a case of PM rupture due to isolated PM infarction in a patient with unobstructed coronary arteries, which could be misdiagnosed as a vegetation or other mass given the absence of regional wall motion abnormalities (RWMAs) on transthoracic echocardiogram. Our case highlights that in patients with severe mitral regurgitation and associated mitral valve mass, the absence of RWMAs should not exclude ischemic PM rupture from differential diagnosis.
- 1 November 2020
- Published by Wiley in Echocardiography
- Vol. 37 (11) , 1855-1859
Isolated papillary muscle rupture with nonobstructive coronary artery disease, minimal myocardial infarction, and normal wall motion
Papillary muscle (PM) rupture can usually complicate inferior or posterior myocardial infarctions, but selective PM infarction is extremely rare, and the exact underlying pathophysiological mechanism is not entirely clear. We present a case of PM rupture due to isolated PM infarction in a patient with unobstructed coronary arteries, which could be misdiagnosed as a vegetation or other mass given the absence of regional wall motion abnormalities (RWMAs) on transthoracic echocardiogram. Our case highlights that in patients with severe mitral regurgitation and associated mitral valve mass, the absence of RWMAs should not exclude ischemic PM rupture from differential diagnosis.
- Open Access
- 1 November 2020
- Published by Elsevier in Hellenic Journal of Cardiology
- Vol. 61 (6) , 415-418
Short-term effects of angiotensin receptor-neprilysin inhibitors on diastolic strain and tissue doppler parameters in heart failure patients with reduced ejection fraction: A pilot trial
- 1 November 2020
- Published by Elsevier in Hellenic Journal of Cardiology
- Vol. 61 (6) , 415-418
Open AccessShort-term effects of angiotensin receptor-neprilysin inhibitors on diastolic strain and tissue doppler parameters in heart failure patients with reduced ejection fraction: A pilot trial